Frew Paula M, Randall Laura A, King Adrian R, Schamel Jay T, Spaulding Anne C, Holloway Ian W
University of Nevada Las Vegas School of Public Health, Las Vegas, NV, United States.
UNLV Population Health & Health Equity Initiative, Las Vegas, NV, United States.
JMIR Res Protoc. 2021 Sep 10;10(9):e25575. doi: 10.2196/25575.
In 2018, 2 million Americans met the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition diagnostic criteria for an opioid use disorder, and 9.9 million Americans had misused prescription pain relievers the previous year. Despite a rapid increase in opioid misuse, opioid use disorders, and overdoses, data are limited on the behavioral and contextual risks as well as the protective factors fueling the opioid epidemic in some hard hit US cities-Atlanta, Los Angeles, and Las Vegas. Opioid use also contributes to the risk of other health problems such as HIV and hepatitis C virus infections or mental health disorders and is linked to behavioral and environmental risks (eg, homelessness, experiences of violence, involvement in the justice system). Knowledge of the relationships between these linked vulnerabilities and how they influence service utilization is critical to effective policy and interventions.
This survey explores the relationships between demographic and economic characteristics, behavioral and environmental risk factors, and service utilization of people who use opioids to inform public health practice, policy, and future efforts to mitigate the risks faced by this population experiencing multiple health, social, and economic vulnerabilities. The results of this survey will be used to identify needs and intervention points for people who use drugs currently served by public health organizations.
We implemented a community-engaged strategy that involved development and execution of a two-stage purposive sampling plan involving selection of partner organizations (syringe exchange programs in urban settings) and recruitment and enrollment of participants aged 18-69 years served by these organizations in Atlanta, Los Angeles, and Las Vegas from 2019 to 2020. The recruited participants completed a survey, including a variety of measures to assess health (physical and mental) and health behaviors such as sexual behavior, vaccine receipt, and HIV/ hepatitis C virus infection testing. Additional items assessed drug use and misuse, syringe exchange and health service utilization, sex exchange, histories of interpersonal violence, and vaccine confidence.
This protocol was successfully implemented despite challenges such as real-time technology issues and rapidly finding and surveying a difficult-to-reach population. We sampled 1127 unique participants (248 in Atlanta, 465 in Los Angeles, and 414 in Las Vegas).
The establishment and utilization of strong community partnerships enabled the rapid collection of data from a typically difficult-to-reach population. Local efforts such as these are needed to develop policies and practices that promote harm reduction among people who use opioids.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/25575.
2018年,200万美国人符合《精神疾病诊断与统计手册》第5版中阿片类药物使用障碍的诊断标准,且前一年有990万美国人滥用过处方止痛药。尽管阿片类药物滥用、阿片类药物使用障碍及过量用药情况迅速增加,但在美国一些受重创城市——亚特兰大、洛杉矶和拉斯维加斯,关于助长阿片类药物流行的行为和背景风险以及保护因素的数据有限。阿片类药物的使用还会增加感染艾滋病毒和丙型肝炎病毒等其他健康问题或心理健康障碍的风险,并与行为和环境风险(如无家可归、暴力经历、卷入司法系统)相关。了解这些相互关联的脆弱性之间的关系以及它们如何影响服务利用情况,对于有效的政策制定和干预措施至关重要。
本次调查旨在探究阿片类药物使用者的人口统计学和经济特征、行为和环境风险因素与服务利用之间的关系,以为公共卫生实践、政策制定以及未来减轻这一面临多种健康、社会和经济脆弱性人群所面临风险的努力提供参考。本次调查结果将用于确定目前由公共卫生组织服务的吸毒者的需求和干预点。
我们实施了一项社区参与策略,其中包括制定和执行两阶段的目的抽样计划,该计划涉及选择合作伙伴组织(城市环境中的注射器交换项目),以及在2019年至2020年期间招募和登记由这些组织在亚特兰大、洛杉矶和拉斯维加斯服务的18至69岁参与者。被招募的参与者完成了一项调查,包括评估健康状况(身体和心理)以及性行为、疫苗接种、艾滋病毒/丙型肝炎病毒感染检测等健康行为的各种指标。其他项目评估了药物使用和滥用情况、注射器交换和健康服务利用情况、性交易、人际暴力史以及疫苗接种信心。
尽管面临实时技术问题以及迅速找到并调查难以接触到的人群等挑战,但该方案仍成功实施。我们共抽样了1127名独特的参与者(亚特兰大有248名,洛杉矶有465名,拉斯维加斯有414名)。
建立并利用强大的社区伙伴关系能够迅速从通常难以接触到的人群中收集数据。需要开展这样的地方工作来制定促进阿片类药物使用者减少伤害的政策和做法。
国际注册报告识别码(IRRID):RR1-10.2196/25575。